Frequently Asked Questions
The market is segmented based on Global Parkinson’s Disorder Drugs Market, By Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Others), Route of Administration (Oral, Injection, Transdermal), Distribution Channel (Hospitals, Online Pharmacy, Others) – Industry Trends and Forecast to 2031.
.
The Global Parkinsons Disorder Drugs Market size was valued at USD 4.60 USD Billion in 2023.
The Global Parkinsons Disorder Drugs Market is projected to grow at a CAGR of 12.9% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, Rest of Middle East and Africa.
